Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women

Annals of Nutrition and Metabolism

Volumn 50, Issue 4, 2006, Pages 387-393

  Fabian, Elisabeth ^a   Elmadfa, Ibrahim ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Healthy women; Lipid profile; Plasma cholesterol; Plasma lipoproteins; Probiotic yoghurt

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL; YOGHURT;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID BLOOD LEVEL; MATHEMATICAL COMPUTING; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-OVER STUDIES; FEMALE; HUMANS; PROBIOTICS; TREATMENT OUTCOME; TRIGLYCERIDES; YOGURT;

EID: 33746821389     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094304     Document Type: Article

References (38)

1. Agerbæk M, Gerdes LU, Richelsen B: Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995;49:346-352.
2. De Roos NM, Schouten G, Katan MB: Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 1999;53:277-280.
3. Richelsen B, Kirstensen K, Pedersen SB: Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double-blind study. Eur J Clin Nutr 1996;50:811-815.
4. Buck LM, Gilliland SE: Comparisons of freshly isolated strains of Lactobacillus acidophilus of human intestinal origin for ability to assimilate cholesterol during growth. J Dairy Sci 1994;77:2925-2933.
5. Klaver FA, van der Meer R: The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 1993;59:1120-1124.
6. De Rodas BZ, Gilliland SE, Maxwell CV: Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet. J Diary Sci 1996;79:2121-2128.
7. De Smet I, Van Hoorde L, De Saeyer N, Vande Woestyne M, Verstraete W: In vitro study of bile salt hydrolase activity of BSH isogenic Lactobacillus plantarum 80 strains and estimation of cholesterol-lowering through enhanced BSH activity. Microb Ecol Health Dis 1994;7:315-329.
8. Pereira DIA, McCartney AL, Gibson GR: An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Env Microbiol 2003;69:4743-4752.
9. Lankaputhra WEV, Shah NP: Survival of Lactobacillus acidophilus and Bifidobacterium spp. in the presence of acid and bile salts. Cult Dairy Prod J 1995;30:2-7.
10. Razin S: Cholesterol incorporation into bacterial membranes. J Bacteriol 1975;124:570.
11. Noh OD, Kim SH, Gilliland SE: Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121. J Dairy Sci 1997;80:3107-3113.
12. Gilliland SE, Nelson CR, Maxwell C: Assimilation of cholesterol of Lactobacillus acidophilus. Appl Environ Microbiol 1997;49:377-381.
13. Pereira DIA, Gibson GR: Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 2002;68:4689-4693.
14. Wolever TM, Fernandes J, Rao AV: Serum acetate:propionate ratio is related to serum cholesterol in Men. J Nutr 1996;126:2790-2797.
15. Delzenne NM, Williams CM: Prebiotics and lipid metabolism. Curr Opin Lipidol 2002; 13:61-67.
16. 1-linked galactosyl residues in glycosphingolipids. Infect Immun 1993;61:3673-3677.
17. Kahn AS, Johnston NC, Goldfine H, Schifferli D M: Porcine 987P glycolipid receptors on intestinal brush borders and their cognate bacterial ligands. Infect Immun 1996;64:3688-3693.
18. Vesper H, Schmelz EM, Nikoloya-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH: Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nut 1999;129:1239-1250.
19. Riboni L, Viani P, Bassi R, Prinetti A, Tettamanti G: The role of sphingolipids in the process of signal transduction. Prog Lipid Res 1997;36:153-195.
20. Kolesnick RN, Krönke M: Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998;60.643-665.
21. Gupta AK, Rudney H: Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity in cell culture. J Lipid Res 1991;32:125-135.
22. Chatterjee S: Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-α in the synthesis of cholesteryl esters in human fibroblasts. J Biol Chem 1994;14:879-882.
23. Zhao Y, Sparks DL, Marcel YL: Specific phospholipids association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins. J Biol Chem 1996; 27:25145-25151.
24. Boldin DJ, Jonas A: Sphingomyelin inhibits the lecithin-cholesterol- acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem 1996;271:19152-19158.
25. Siedel J, Hagele EO, Ziegenhom J, Wahlfeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipophilic efficiency. Clin Chem 1983;29:1075-1080.
26. Burstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-595.
27. Siedel J, Schmuck R, Staepels J, Town MH: Long-term stable, liquid ready-to-use monoreagent for the enzymatic assay of serum or plasma triglycerides (GPO-PAP method). Clin Chem 1993;39:1127.
28. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29. Gordon DJ, Probsfield L, Garrison RJ, Neaton JD, Castelli WP, Konke JD, Jakobs DR, Bangdiwala S, Tyroler A: High density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:8-15.
30. Schaafsma G, Meulig WJA, van Dokkum W, Bouley C: Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 1998; 52:436-440.
31. Anderson JW, Gilliland SE: Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 1999;18:43-50.
32. Bertolami MC, Faludi A A, Batlouni M: Evaluation of the effect of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 1999;53:97-101.
33. Taylor GR, Williams CM: Effects of probiotics and prebiotics on blood lipids. Br J Nurt 1989;80:S225-230.
34. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A: Effect of 8 week intake of probiotic milk products on cardiovascular diseases. Eur J Clin Nutr 2000;54:288-297.
35. Schaarmann G, Schneider J, Zorn A, Vilser C, Jahreis G: Influence of probiotic yoghurt on serum lipids in women. Am J Clin Nutr 2001;73:496S.
36. Kiessling G, Schneider J, Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002;56:843-849.
37. Smedman AEM, Gustafsson IB, Berglund LGT, Vessby BOH: Pentadevanoic acid in serum as a marker for intake of milk fat and metabolic risk factors. Am J Cin Nutr 1999; 69:22-29.
38. Shah NP: Probiotic bacteria: selective enumeration and survival in dairy foods. J Dairy Sci 1999;83:894-907.